Friday, July 21, 2017 12:40:08 PM
Spidroin-1, is the protein responsible for the great strength of spider drag line silk.
It is a Very Large Very long chain protein with a molecular weight ( a parameter that measures chain length of polymers) in the thousands.
Bacteria and yeasts simply are not large enough or complex enough to produce proteins of such high MW.
I will leave it to Jazz710 to attempt to explain the biologic production differences, but most simply put, bacteria and yeasts are simply too small and primitive to produce very long chain polymers.
KBLB's transgenic genes are closely similar in size to the original spider / spidroin-1 genes.
They contain unique synthetic coupling and promoter regions that enable them to function in the silkworm.
In contrast the genes used by the bacterial and yeast production methods are much smaller, producing much shorter, lower MW, analogs of spidroin-1, with MW in the range of 50 to 500.
The source for all of this is from papers and publication put out a few years ago by Amsilk, the first Bacterial production company.
At that time they were still hoping to make strong long fiber.
All indicators now seem to be that they have abandoned those attempts.
Someone actually did a study of the effect of gene and protein chain length on the strength of the final fiber. SURPRISE! the shorter chain molecules produced much weaker fibers!
What we have been seeing recently seems to indicate that Bolt Threads has also given up and left the competition to produce strong fiber, concentrating instead on fashion and environment. (Which in my opinion is BS, The brewing process produces tons of waste for every pound of fiber.)
Mike L.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM